Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients.


BACKGROUND When inhaling medication, it is essential that drug particles are delivered to all sites of lung inflammation, including the peripheral airways. The aim of this study was to assess the lung deposition and lung distribution of beclomethasone dipropionate (BDP)/formoterol (100/6 microg), both dissolved in hydrofluoroalkane (HFA) and delivered by… (More)
DOI: 10.1089/jamp.2009.0772